Boston Therapeutics, Inc.
New Filing
CIK: 0001473579·Pharmaceuticals·DELAWARE·Filed: Aug 7, 2013
Total Offering
$8,000,000
Amount Sold
$2,000,000
Investors
1
First Sale
Jul 23, 2013
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506
- Entity Type
- Corporation
- Year Incorporated
- 2009
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| David Platt, Ph. D. | Related Person |
| Kenneth Tassey, Jr. | Related Person |
| Dale H. Conaway | Related Person |
| Carl Lueders | Related Person |
| Rom Eliaz | Related Person |
| Henry Esber | Related Person |
Company
SEC Filing
0001102624-13-000940
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free